Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | GGT1 | P19440 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6010128 | 0.98 | FOLH1 (0.43) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL6010380 | 0.95 | FOLH1 (0.39) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL6009834 | 0.80 | TGFBR1 (0.40) | CA1CA2 | |
| SCHEMBL28491840 | 0.80 | KMT2A (0.38) | FOLH1MMP2MMP9CA1CA2 | |
| SCHEMBL6010454 | 0.80 | FOLH1 (0.46) | FOLH1 | |
| SCHEMBL6009547 | 0.78 | FOLH1 (0.44) | FOLH1 | |
| SCHEMBL30935981 | 0.77 | FOLH1 (0.54) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL4100264 | 0.76 | FOLH1 (0.47) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL4087629 | 0.76 | FOLH1 (0.47) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL27259500 | 0.76 | TGFBR1 (0.37) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | FOLH1 1267/4885GSR 809/4885RNPEP 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.